Efficacy of nebulized liposomal amphotericin B in treatment of experimental pulmonary aspergillosis

被引:42
|
作者
Gavaldà, J [1 ]
Martín, MT [1 ]
López, P [1 ]
Gomis, X [1 ]
Ramírez, JL [1 ]
Rodríguez, D [1 ]
Len, O [1 ]
Puigfel, Y [1 ]
Ruíz, I [1 ]
Pahissa, A [1 ]
机构
[1] Univ Autonoma Barcelona, Hosp Univ Valle Hebron, Div Infect Dis, Infect Dis Res Lab, E-08193 Barcelona, Spain
关键词
D O I
10.1128/AAC.49.7.3028-3030.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The efficacy of therapeutic aerosolized amphotericin B (AMB) was studied in a steroid-immunosuppressed murine model of invasive pulmonary aspergillosis. Nebulized liposomal AMB can be a valid approach to the treatment of this infection, with subjects showing significantly improved survival relative to that of subjects given intravenous deoxycholate AMB, as well as lower lung weights and pulmonary glucosamine levels.
引用
收藏
页码:3028 / 3030
页数:3
相关论文
共 50 条
  • [1] Efficacy of high loading doses of liposomal amphotericin B in the treatment of experimental invasive pulmonary aspergillosis
    Gavaldà, J
    Martín, T
    López, P
    Gomis, X
    Ramírez, JL
    Rodríguez, D
    Len, O
    Puigfel, Y
    Ruiz, I
    Pahissa, A
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (12) : 999 - 1004
  • [2] Efficacy of high doses of liposomal amphotericin B in the treatment of experimental aspergillosis
    Martín, MT
    Gavaldà, J
    López, P
    Gomis, X
    Ramírez, JL
    Rodríguez, D
    Len, O
    Jordano, Q
    Ruiz, I
    Rosal, M
    Almirante, B
    Pahissa, A
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (06) : 1032 - 1034
  • [3] Aspergillosis: Nebulized liposomal amphotericin-B for maintenance therapy?
    Simon, Annika
    [J]. PNEUMOLOGIE, 2023, 77 (01): : 8 - 8
  • [4] Efficacy of aerosolized amphotericin B desoxycholate and liposomal amphotericin B in the treatment of invasive pulmonary aspergillosis in severely immunocompromised rats
    Ruijgrok, EJ
    Vulto, AG
    Van Etten, EWM
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (01) : 89 - 95
  • [5] Efficacy and safety of generic amphotericin B in experimental pulmonary aspergillosis
    Petraitis, V
    Petraitiene, R
    Lin, PX
    Calis, K
    Kelaher, AM
    Muray, HA
    Mya-San, C
    Mickiene, D
    Bacher, J
    Walsh, TJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (04) : 1642 - 1645
  • [6] Efficacy of liposomal amphotericin B with prolonged circulation in blood in treatment of severe pulmonary aspergillosis in leukopenic rats
    Van Etten, EWM
    Stearne-Cullen, LET
    Ten Kate, MT
    Bakker-Woudenberg, IAJM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (03) : 540 - 545
  • [7] Efficacy of liposomal amphotericin B for prophylaxis of acute or reactivation models of invasive pulmonary aspergillosis
    Leleu, Christopher
    Menotti, Jean
    Meneceur, Pascale
    Choukri, Firas
    Sulahian, Annie
    Garin, Yves J. -F.
    Derouin, Francis
    [J]. MYCOSES, 2013, 56 (03) : 241 - 249
  • [8] Comparative Study on the Efficacy of Liposomal Amphotericin B and Voriconazole in a Murine Pulmonary Aspergillosis Model
    Takemoto, Koji
    Yamamoto, Yutaka
    Ueda, Yutaka
    Kanazawa, Katsunori
    Yoshida, Koichiro
    Niki, Yoshihito
    [J]. CHEMOTHERAPY, 2009, 55 (02) : 105 - 113
  • [9] Nebulized amphotericin B combined with intravenous amphotericin B in rats with severe invasive pulmonary aspergillosis
    Ruijgrok, EJ
    Fens, MHAM
    Bakker-Woudenberg, IAJM
    van Etten, EWM
    Vulto, AG
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (05) : 1852 - 1854
  • [10] Impact of liposomal amphotericin B therapy on chronic pulmonary aspergillosis
    Newton, Pippa J.
    Harris, Chris
    Morris, Julie
    Denning, David W.
    [J]. JOURNAL OF INFECTION, 2016, 73 (05) : 485 - 495